Archives

by in
Entry Author Date Location
Sage Therapeutics Shifts Gears, Focuses on Rare Form of Epilepsy 04/17/13 Boston
East Coast Life Sciences Roundup: Pfizer, J&J, Alkermes, More 01/04/13 Boston
Alkermes Aims for Psychiatric Drug That Won’t Pack on the Pounds 01/03/13 Boston
From One Japanese Backer to Another: Galenea Advances Brain Drugs 07/19/12 Boston
EnVivo, Biogen, Momenta, & Other Boston-Area Life Sciences Newsmakers 12/09/11 Boston
EnVivo Posts Positive Trial of Schizophrenia Drug 12/05/11 Boston
Third Rock Launches Sage Therapeutics with $35M Series A and Plan to Tackle Brain Diseases 10/18/11 Boston
Stealthy Karuna Licenses Schizophrenia Drugs from Vanderbilt 09/28/11 Boston
EnVivo, Backed by Fidelity Biosciences, Tests New Weapon Against Alzheimer’s 07/25/11 Boston
Zogenix Strategy Unfolds as it Unveils Plans for Next Drug-and-Device Combo 07/19/11 San Diego
Alkermes Wins Over Investors With Plan To Become Trans-Atlantic “Big Biotech” 07/06/11 Boston
Alkermes Acquires Elan Drug Manufacturing Unit for $960M 05/09/11 Boston
Vertex Drug Gets Speedy FDA Review, BSX Buys Atritech, Ironwood Strikes Another Deal, & More Boston-Area Life Sciences News 01/21/11 Boston
Ex-Pfizer Exec Ed Harrigan Takes Top Job at Secretive Karuna Pharmaceuticals 01/20/11 Boston
Allon Starts Trial for Brain Disease 01/06/11 Seattle
Biogen Announces Restructuring, FDA Approves Sunovion Drug, Acceleron Cuts Workforce, & More Boston-Area Life Sciences News 11/05/10 Boston
Allon Therapeutics Adds $10M 11/01/10 Seattle
FDA Approves Sunovion Schizophrenia Drug 10/29/10 Boston
Alkermes Drug Approved for Opioid Addiction, Genzyme Faces Shareholder Lawsuits, NinePoint Gets $33M, & More Boston-Area Life Sciences News 10/15/10 Boston
A Nobel Laureate’s Stealthy Biotech, Its Japanese Pharma Backer, and the Englishman In Charge 10/14/10 Boston
BrainCells Inc. Buys Neuro Drug 08/04/10 San Diego
Alkermes Reveals Higher-Than-Expected Royalty on Diabetes Drug 04/26/10 Boston
Allon Treads Into the Great Unknown, Alzheimer’s Disease, With New Kind of Drug 04/06/10 Seattle
San Diego’s Acadia Pharmaceuticals Updates Plans for Experimental Parkinson’s Drug 03/10/10 San Diego
AFraxis CEO Outlines Biotech’s Success With Ultra-Lean Pre-Clinical R&D in Russia 02/26/10 San Diego
NIH Chief Stresses Economic Impact of Federal Biomedical Funding 02/22/10 San Diego
Alkermes Unveils Cheaper, Easier Technique for Making Drugs Last Longer in Blood 02/04/10 Boston
Alkermes Bets $10M on Long-Lasting Drug Technology from Startup Neighbor, Acceleron 12/03/09 Boston
Omeros, First U.S. Biotech IPO Since February 2008, Sees Shares Drop 13 Percent in First Day 10/08/09 Seattle
Omeros Plans to Test Waters with First Washington IPO in Two Years, Sources Say 08/26/09 Seattle
Page 1 of 2 next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  3. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  4. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
  5. Do You Need an Extended Warranty? Do the Math, Says SquareTrade

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.